Nishio K - Search Results

1

Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition.

Okamoto W, Okamoto I, Yoshida T, Okamoto K, Takezawa K, Hatashita E, Yamada Y, Kuwata K, Arao T, Yanagihara K, Fukuoka M, Nishio K, Nakagawa K. Okamoto W, et al. Among authors: nishio k. Mol Cancer Ther. 2010 May;9(5):1188-97. doi: 10.1158/1535-7163.MCT-10-0002. Epub 2010 Apr 20. Mol Cancer Ther. 2010. PMID: 20406949

2

Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin.

Niimi S, Nakagawa K, Sugimoto Y, Nishio K, Fujiwara Y, Yokoyama S, Terashima Y, Saijo N. Niimi S, et al. Among authors: nishio k. Cancer Res. 1992 Jan 15;52(2):328-33. Cancer Res. 1992. PMID: 1345810

3

Characterization of an etoposide-resistant human small-cell lung cancer cell line.

Minato K, Kanzawa F, Nishio K, Nakagawa K, Fujiwara Y, Saijo N. Minato K, et al. Among authors: nishio k. Cancer Chemother Pharmacol. 1990;26(5):313-7. doi: 10.1007/BF02897284. Cancer Chemother Pharmacol. 1990. PMID: 1976450

4

Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.

Niimi S, Nakagawa K, Yokota J, Tsunokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M, Saijo N. Niimi S, et al. Among authors: nishio k. Br J Cancer. 1991 Feb;63(2):237-41. doi: 10.1038/bjc.1991.56. Br J Cancer. 1991. PMID: 1997100 Free PMC article.

5

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.

Nishio K, Sugimoto Y, Nakagawa K, Niimi S, Fujiwara Y, Bungo M, Kasahara K, Fujiki H, Saijo N. Nishio K, et al. Br J Cancer. 1990 Sep;62(3):415-9. doi: 10.1038/bjc.1990.309. Br J Cancer. 1990. PMID: 2206949 Free PMC article.

6

Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G(1) phase of the cell cycle.

Fukuoka K, Yamagishi T, Ichihara T, Nakaike S, Iguchi K, Yamada Y, Fukumoto H, Yoneda T, Samata K, Ikeya H, Nanaumi K, Hirayama N, Narita N, Saijo N, Nishio K. Fukuoka K, et al. Among authors: nishio k. Int J Cancer. 2000 Dec 1;88(5):810-9. doi: 10.1002/1097-0215(20001201)88:5<810::aid-ijc20>3.0.co;2-p. Int J Cancer. 2000. PMID: 11072253

7

CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.

Shimizu M, Tamura T, Yamada Y, Akiyama Y, Saijo N, Nishio K. Shimizu M, et al. Among authors: nishio k. Jpn J Cancer Res. 2001 May;92(5):554-61. doi: 10.1111/j.1349-7006.2001.tb01129.x. Jpn J Cancer Res. 2001. PMID: 11376565 Free PMC article.

8

Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.

Yoshida M, Suzuki T, Komiya T, Hatashita E, Nishio K, Kazuhiko N, Fukuoka M. Yoshida M, et al. Among authors: nishio k. Int J Cancer. 2001 Nov 1;94(3):432-7. doi: 10.1002/ijc.1490. Int J Cancer. 2001. PMID: 11745426

9

Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474.

Arao T, Fukumoto H, Takeda M, Tamura T, Saijo N, Nishio K. Arao T, et al. Among authors: nishio k. Cancer Res. 2004 Dec 15;64(24):9101-4. doi: 10.1158/0008-5472.CAN-04-2360. Cancer Res. 2004. PMID: 15604279

10

Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients.

Nishio M, Ohyanagi F, Horiike A, Ishikawa Y, Satoh Y, Okumura S, Nakagawa K, Nishio K, Horai T. Nishio M, et al. Among authors: nishio k. Br J Cancer. 2005 May 23;92(10):1877-80. doi: 10.1038/sj.bjc.6602585. Br J Cancer. 2005. PMID: 15870715 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,209 results

Search Page

Filters